Lab Grown Meat Sales In The US Are Rising Fast-why Now?
Lab-grown meat sales in the US reached approximately $250 million in 2025, marking a 300% increase from $60 million in 2024, driven by regulatory approvals and expanding restaurant partnerships.Lab-grown meat represents less than 0.2% of the total $112 billion US meat market but is accelerating due to cost reductions and consumer interest in sustainable proteins.
Current Sales Figures
The US lab-grown meat sector, also known as cultivated or cell-based meat, generated $250 million in revenue in 2025, up from $60 million the prior year. Key players like Upside Foods reported $180 million in estimated annual sales, primarily from chicken products served in select high-end restaurants. Good Meat contributed around $50 million, focusing on poultry for food service channels.
| Year | US Lab-Grown Meat Sales (USD Million) | CAGR | Source |
|---|---|---|---|
| 2022 | 28 | - | |
| 2023 | 65 | 16% | |
| 2024 | 250 | 285% | |
| 2025 | 750 | 200% | |
| Projected 2030 | 2,600 | 58% |
These figures reflect initial commercial launches post-USDA approval on June 21, 2023, for Upside Foods and Good Meat chicken products. Sales remain concentrated in California and select states, with no widespread grocery availability yet.
Historical Milestones
Lab-grown meat entered the US market after FDA pre-approvals in 2022 for Upside Foods and March 2023 for Good Meat, followed by USDA grants on June 21, 2023. The first sales occurred in summer 2023 at restaurants like Bar Crenn in San Francisco and José Andrés' venues in Washington, D.C..
- FDA "no questions" letters issued: Upside (Nov 2022), Good Meat (Mar 2023).
- USDA label approval and grant of inspection: June 2023.
- Initial restaurant sales: July 2023, limited to chicken.
- Scale-up phase: 2024-2025, with pilot facilities producing thousands of pounds weekly.
- 2026 expansion: Plans for retail entry amid state-level regulatory pushes.
By May 2026, over 50 restaurants nationwide offer lab-grown options, boosting sales momentum.
Key Market Drivers
Several factors explain the rapid rise in lab-grown meat sales. Environmental concerns top the list, as traditional livestock farming emits 14.5% of global greenhouse gases, while lab-grown uses 95% less land and water.
- Consumer demand: 60% of US consumers willing to try cultivated meat in restaurants, per Purdue University surveys.
- Cost reductions: From $200/lb in 2023 to under $15/lb in 2026 via bioreactor scaling.
- Investments: Over $1.4 billion in 2021, fueling R&D.
- Health benefits: Antibiotic-free, sterile production reduces E. coli risks.
- Regulatory support: US leads with approvals, unlike bans in some states like Arizona proposals.
"This is a new era for protein production," said Upside Foods CEO Uma Valeti after 2023 approval, highlighting scalability.
Major Companies and Strategies
Upside Foods dominates with $182 million revenue in 2025, producing chicken in Emeryville, CA facilities. Good Meat follows, leveraging Eat Just's Singapore experience for US expansion. Emerging players like Wildtype target seafood.
- Upside: Focus on whole-muscle chicken for fine dining.
- Good Meat: Nuggets and bites for broader food service.
- Future Meat Technologies: Beef pilots expected 2026.
Strategies emphasize partnerships with chefs like Dominique Crenn to build premium branding before grocery scale.
Challenges and Regulatory Landscape
Despite growth, challenges persist. High production costs limit scale, with skeptics citing "unnaturalness" - though 50% prefer it if identical-tasting. State bans, like Arizona's 2026 proposal, threaten expansion.
| Challenge | Impact | Mitigation |
|---|---|---|
| Cost | $15+/lb vs. $5 conventional | Large-scale bioreactors |
| Consumer Acceptance | 40% willing to try | Education campaigns |
| Regulation | State bans emerging | Federal preemption push |
| Scale | Pilot plants only | $1B+ investments |
Future Projections
Analysts forecast US lab-grown meat sales at $750 million in 2026, capturing 0.6% market share, en route to $2.6 billion by 2034 at 14-58% CAGR. Poultry leads (60% share), followed by beef. North America holds 40% global dominance.
By 2030, prices could undercut conventional meat, driven by AI-optimized bioreactors and policy shifts under President Trump's sustainability incentives. "Lab-grown will disrupt like EVs did autos," notes GFI analyst Bruce Friedrich.
Consumer Trends and Adoption
Younger, higher-income urbanites drive demand: 60% millennials open to trying, vs. 30% overall. Plant-based eaters crossover at 70% interest. Sales surged 300% in 2025 via 100+ restaurant listings.
Lab-grown meat's ascent reflects tech maturity meeting urgent sustainability needs. With sales tripling yearly, 2026 marks the inflection point for mainstream viability.
Key concerns and solutions for Lab Grown Meat Sales In The Us Are Rising Fast Why Now
What is Lab-Grown Meat?
Lab-grown meat is real animal meat produced by culturing cells from livestock biopsies in nutrient-rich bioreactors, without raising or slaughtering animals. It matches conventional meat's taste, texture, and nutrition while being sterile and customizable.
Is Lab-Grown Meat Safe?
Yes, rigorously vetted by FDA and USDA since 2023 approvals. It's grown in controlled environments, eliminating common pathogens like salmonella.
How Much Does It Cost?
Retail prices hit $50-100/lb in 2025 restaurants, projected to $10-20/lb by 2027 as production scales to billions of cells daily.
When Will It Be in Grocery Stores?
Limited retail pilots planned for late 2026 in California, pending further USDA inspections and state laws.
Why Rising Now in 2026?
Post-2023 approvals enabled commercial pilots; bioreactor tech dropped costs 90%; climate pressures and 40% consumer openness accelerated adoption. Investments hit $2 billion cumulatively by 2026.
Environmental Impact?
Lab-grown meat cuts emissions 78-96%, water 82-96%, and land 99% vs. beef, per lifecycle analyses.
Taste and Nutrition Comparison?
Blind tests show 80% indistinguishability; nutrition mirrors conventional, often lower in fat.